Table 4.
E’/A' | E/E’ | S' | ||||
---|---|---|---|---|---|---|
Estimate | P | Estimate | P | Estimate | P | |
Intercept | −0.28 ± 0.14 | 0.05 | 0.09 ± 0.50 | 0.86 | −0.59 ± 0.39 | 0.14 |
Age (years) | −0.008 ± 0.008 | 0.27 | 0.04 ± 0.03 | 0.2 | 0.05 ± 0.02 | 0.03 |
Height Z-score | −0.03 ± 0.03 | 0.35 | −0.26 ± 0.10 | 0.008 | −0.001 ± 0.08 | 0.98 |
Male sex | 0.57 ± 0.16 | 0.0009 | ||||
eGFR | 0.008 ± 0.002 | 0.002 | −0.003 ± 0.008 | 0.71 | −0.01 ± 0.006 | 0.07 |
Systolic BP Z-score | −0.07 ± 0.02 | 0.02 | ||||
ACEi/ARB therapy | 0.13 ± 0.05 | 0.02 | −0.37 ± 0.19 | 0.05 | ||
E/E' | −0.05 ± 0.03 | 0.08 | −0.40 ± 0.08 | <0.0001 | ||
Concentric LV hypertrophy | 0.08 ± 0.06 | 0.18 | −0.25 ± 0.16 | 0.13 |
eGFR, estimated Glomerular Filtration rate (ml/min/1.73 m2); ACE, Angiotensine converting enzyme inhibitor; ARB, Angiotensine receptor blockade, E/E’ Early conventional to tissue Doppler diastolic velocity (cm/s); LV, left ventricular.